Attached files

file filename
EX-99.1 - PRESS RELEASE - CRYO CELL INTERNATIONAL INCd376468dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 3, 2012

 

 

CRYO CELL International, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   000-23386   22-3023093

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(I.R.S. Employer

Identification No.)

700 Brooker Creek Boulevard, Oldsmar, Florida   34677
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (813) 749-2100

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events.

On July 3, 2012, Cryo-Cell International, Inc. (the “Company”) issued the attached Press Release. The press release is attached as Exhibit 99.1 to this report.

 

Item 9.01. Financial Statements and Exhibits.

 

(a)    Financial Statements of Businesses Acquired.    Not Applicable.
(b)    Pro Forma Financial Information    Not Applicable.
(c)    Shell Company Transactions    Not Applicable.
(d)    Exhibits.   
   Exhibit Number    Description
      Press Release dated July 3, 2012.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

      CRYO-CELL International, Inc.
DATE: July 3, 2012     By:  

/s/ David I. Portnoy

      David I. Portnoy
      Co-Chief Executive Officer

 

3